18:00 , May 11, 2018 |  BC Week In Review  |  Financial News

AxoGen raises $123M in upsized follow-on

AxoGen Inc. (NASDAQ:AXGN) raised $123 million on May 9 through the sale of 3 million shares at $41 in an upsized follow-on underwritten by Jefferies, Leerink Partners, William Blair and JMP Securities. The price is...
18:07 , May 9, 2018 |  BC Extra  |  Financial News

AxoGen raises $123M in upsized follow-on

AxoGen Inc. (NASDAQ:AXGN) raised $123 million through the sale of 3 million shares at $41 in an upsized follow-on underwritten by Jefferies, Leerink Partners, William Blair and JMP Securities. The price is a 5% discount...
00:43 , Jan 13, 2018 |  BioCentury  |  Finance

Choosy investors

  Despite losing steam in 4Q17, the broad-based recovery in biotech stocks last year has left investors generally comfortable with current valuations, and hence less optimistic that the sector indexes will outpace the broader market...
22:15 , Jan 6, 2017 |  BioCentury  |  Finance

Good riddance

  Investors aren’t lamenting the end of 2016, but they are pinned between anxiety and optimism for the year ahead. The anxiety stems from uncertainty about U.S. government policies for healthcare under the new administration....
07:00 , Oct 31, 2016 |  BC Week In Review  |  Financial News

AxoGen Inc. completes debt financing

AxoGen Inc. (NASDAQ:AXGN), Alachua, Fla.  Business: Neurology  Date completed: 2016-10-26  Type: Debt financing  Raised: $21 million  Investor: MidCap Financial  Note: The 54-month term loan bears interest at 8% plus the greater of 0.5% or LIBOR. ...
07:00 , Oct 31, 2016 |  BC Week In Review  |  Financial News

AxoGen Inc. completes debt financing

AxoGen Inc. (NASDAQ:AXGN), Alachua, Fla.  Business: Neurology  Date completed: 2016-10-26  Type: Debt financing  Raised: $4 million  Investor: MidCap Financial  Note: AxoGen drew down $4 million of a new $10 million revolving line of credit. The...
07:00 , Oct 17, 2016 |  BC Week In Review  |  Financial News

AxoGen Inc. completes follow-on

AxoGen Inc....
07:00 , Apr 21, 2014 |  BioCentury  |  Finance

Undiluted injection

Undiluted injection Kaleo Inc. is leveraging the royalties from its first marketed product to secure the non-dilutive funding it needs to launch its second product, an auto-injectable form of naloxone to treat opioid overdose. After...
07:00 , Oct 7, 2013 |  BioCentury  |  Finance

4Q Financial Markets Preview: Room to grow - for now

Even as biotech indices surpass all-time highs, investors are saying there is more room to run. While buysiders and bankers do expect the pace of growth to slow in the coming year, they think the...
07:00 , Aug 12, 2013 |  BC Week In Review  |  Financial News

AxoGen Inc. completes follow-on

AxoGen Inc. (NASDAQ:AXGN), Alachua, Fla.   Business: Neurology   Date completed: 8/9/13   Type: Follow-on   Raised: $18 million   Shares: 6 million   Price: $3   Shares after offering: 17.1 million   Underwriters: JMP...